EpiVax to advance development of vaccine against flu virus with $600,000 federal grant – URI Today : uri

as informed in uri

EpiVax to advance development of vaccine against flu virus with $600,000 federal grant – URI Today

EpiVax to advance development of vaccine against flu virus with $600,000 federal grant – URI Today

Annie De Groot, a research professor at the University of Rhode Island.Photo courtesy of URI.KINGSTON, R.I., Sept. 21, 2016—University of Rhode Island Research Professor Annie De Groot and her team at EpiVax have been awarded a $600,000 grant from the National Institutes of Health to improve a vaccine for the H7N9 avian influenza virus.


not to mention providencejournal

URI professor and her biotech company win NIH grant to improve avian flu vaccine

URI professor and her biotech company win NIH grant to improve avian flu vaccine

Sign up for our newsletter and have the top headlines from your community delivered right to your inbox


furthermore winknews

CDC changes flu vaccine recommendation

CDC changes flu vaccine recommendation

CDC changes flu vaccine recommendation(CONSUMER REPORTS) Flu season is right around the corner, and we all know that getting a vaccine is the best defense against the illness.But depending on your age and health, you may need to change the type of vaccine you get.This year, the Centers for Disease Control and Prevention isn't recommending the nasal vaccine FluMist.


as well fox13now

Nasal spray vaccine not recommended for 2016-17 flu season, according to CDC

Nasal spray vaccine not recommended for 2016-17 flu season, according to CDC

Please enable Javascript to watch this videoSALT LAKE CITY –A less painful option to protect against influenza has been taken away.FluMist nasal spray is not being recommended for use during the 2016-17 flu season because of concerns about its effectiveness, according to the The Center for Disease Control and Prevention.Health experts say the flu shot is the best option to vaccinate against the virus.